|
Video: What is a Stock Split?
|
|
Creative Medical Technologies Holdings is a biotechnology company focused on urology, orthopedics and neurology using adult stem cell treatments. Co. conducts its commercial operations through Creative Medical Technologies, Inc. (CMT). CMT markets and sells Co.'s CaverStem® and FemCelz® disposable kits utilized by physicians to perform autologous procedures that treat erectile dysfunction and female sexual dysfunction, respectively. Co.'s CaverStem® and FemCelz® kits are available through physicians at 12 locations in the United States and Europe. Co. is focused on the commercial sale and use of CaverStem® and FemCelz® by physicians, and its StemSpine® treatment for lower back pain. According to our Creative Medical Technology Holdings stock split history records, Creative Medical Technology Holdings has had 1 split. | |
|
Creative Medical Technology Holdings (CELZ) has 1 split in our Creative Medical Technology Holdings stock split history database. The split for CELZ took place on June 12, 2023. This was a 10 for 1 split, meaning for each share of CELZ owned pre-split, the shareholder now owned 10 shares. For example, a 1000 share position pre-split, became a 10000 share position following the split.
When a company such as Creative Medical Technology Holdings splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the Creative Medical Technology Holdings stock split history from start to finish, an original position size of 1000 shares would have turned into 10000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Creative Medical Technology Holdings shares, starting with a $10,000 purchase of CELZ, presented on a split-history-adjusted basis factoring in the complete Creative Medical Technology Holdings stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
12/16/2020 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$0.00 |
|
End price/share: |
$4.32 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
431,999,900.00% |
|
Average Annual Total Return: |
9,351.28% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$43,199,984,820.40 |
|
Years: |
3.36 |
|
|
|
Date |
Ratio |
06/12/2023 | 10 for 1 |
|
|